Elite Pharmaceuticals Files ANDA for Oxycodone Hydrochloride Extended Release Pharmaceutical Investing
Revive Therapeutics Enters License Agreement for Cannabinoids-Based Therapeutics Pharmaceutical Investing
DelMar Pharmaceuticals Receives IND Allowance from FDA to Initiate Clinical Trials of VAL-083 for the Treatment of Ovarian Cancer Pharmaceutical Investing
Soleno Therapeutics Presents Updated Safety and Efficacy Data from Clinical Trial Pharmaceutical Investing
